lightbulb without background

0845 388 0302

Primary Care Support

Federations, Practice Mergers, Income Generation & Access

Logo Header 12th april 2017Artboard 1@2x

Partnering with the NHS

For the Pharmaceutical Industry to be viewed as a partner, you need to understand the current NHS agenda, the evolution of New Models of Care and the intended impact of Sustainability and Transformation Partnerships (STPs.


Whether it’s hubs of 30,000 to 50,000 (e.g. Primary acre Home – PCH), Multispecialty Community Providers (MCP), Primary and Acute Care Systems (PACS), Accountable Care Systems (ACS) or Accountable Care Organisations (ACO), I can explain the differences and demonstrate how you can engage with the right client base using only six questions.









As we head towards the end of another calendar year, many of you will be planning your target accounts for 2018 and agreeing your priorities.  That  end of year planning round will undoubtedly be affected by what’s happening within your client base, where the NHS landscape continues to change and the many financial and service challenges continue.


Time and finances are at a premium, regulation is stricter than it has ever been and access is getting harder to achieve in the traditional model.  Pharmaceutical companies who have historically worked in partnership with the NHS are more frequently experiencing greater difficulty in accessing their main marketplace.  Often the access that is achieved does not bring the results required.


There is a solution; a new client base you can target that will engage, work with you and seek out joint initiatives that deliver improved patient outcomes within financially viable solutions.


Within Scott McKenzie UK we already have many successful live examples; models that effectively support the Practices to transform clinical vision into reality, for example creating more cost-effective treatment pathways, delivering significant efficiency for the practices, supporting seven day opening and working with other key health economy stakeholders.


Many of these projects are worked via the newly formed GP Federations, Super Practices, Hubs of 30,000 to 50,000 patients and many are working in partnership with the pharmaceutical industry.


Our process ensures a unique approach for each Pharmaceutical Company, one that best reflects your own circumstances, ways of working and relationships; there is no one size that will fit every need, hence we support you to turn your vision into reality ­ this is where our proven methods are ideal.



I will teach you the techniques I use and how to do what I do.

I will also provide three unique strategies to accelerate your access and your sales....

If you would welcome a unique and different insight in to the working of the new NHS, or simply want to discuss further how I can support you turn the vision in to reality, if require more information, or want to design and unique workshop, please contact Frances on 0845 388 0302